Renvela brings up questions about how to choose a phosphate binder for patients with chronic kidney disease

August 2011

The new product, Renvela, brings up questions about how to choose a phosphate binder for patients with chronic kidney disease.

These have similar efficacy for lowering phosphate levels...but vary in adverse effects, cost, and pill burden.

Aluminum hydroxide isn't used chronically anymore. Aluminum accumulates and leads to bone disease, dementia, and death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Cardiology Canadian antiplatelet guidelines recommend AGAINST using aspirin routinely for primary prevention
Statins if statins increase the risk of diabetes
Respiratory & Allergy which long-acting bronchodilator to use first-line for COPD
Nephrology Renvela brings up questions about how to choose a phosphate binder for patients with chronic kidney disease
Men's Health Men are asking if they should continue taking finasteride (Proscar, etc) or dutasteride (Avodart)
Men's Health Drug interactions continue to be a source of problems with phosphodiesterase 5 (PDE5) inhibitors
Psychiatry New guidelines for post-traumatic stress disorder
Infectious Diseases when to use TOPICAL antifungals for oral candidiasis
Infectious Diseases You wouldn't think IV dexamethasone would be a good idea for a patient hospitalized with community-acquired pneumonia (CAP)
Cystitis whether Cystoplus (sodium citrate) is effective for pain from bladder infections
Vitamins & Minerals Is it ever necessary to give vitamin B12 by injection
Smoking Cessation new warnings concerning Champix and an increased risk of cardiac events in patients with heart disease